@article{article, title  = {{Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747)}},

 url = {{https://eprints.whiterose.ac.uk/104430/ }},

 year = {{2016}},

 month = {{6}},

 author = {{Andronis L and Goranitis I and Pirrie S and Pope A and Barton D and Collins S and Daunton A and McLaren D and O'Sullivan JM and Parker C and Porfiri E et al}},

 doi = {{10.1111/bju.13549}},

 journal = {{BJU International}},

 note = {{Accessed on 2024/12/27}}}